Submit Manuscript  

Article Details


The Non-Canonical IκB Kinases IKKε and TBK1 as Potential Targets for the Development of Novel Therapeutic Drugs

[ Vol. 13 , Issue. 7 ]

Author(s):

E. Niederberger, C. V. Moser, K. L. Kynast and G. Geisslinger   Pages 1089 - 1097 ( 9 )

Abstract:


IκB kinase epsilon (IKKε) and TANK-binding kinase 1 (TBK1) are two non-canonical IKKs which are involved in interferon regulatory factor (IRF) as well as nuclear factor kappaB (NF-κB) signaling cascades. Both kinases have already been linked to the pathophysiology of several diseases and therefore been suggested as potential promising targets for the development of therapeutic drugs. In this review, we summarize the roles of IKKε and TBK1 in different diseases and outline therapeutic options for modulation of these kinases.

Keywords:

Cancer, IKKε, inflammation, interferon regulatory factor, NF-κB, TBK1.

Affiliation:

Pharmazentrum frankfurt/ZAFES, Institut fur Klinische Pharmakologie, Klinikum der Johann Wolfgang Goethe-Universitat Frankfurt, Theodor Stern Kai 7, D-60590 Frankfurt am Main, Germany.



Read Full-Text article